drugset / Trial / NCT05516953

Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery

NCT05516953

Phase 2/3 Completed 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aims to evaluate the possible efficacy of baclofen on postoperative nausea and vomiting in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.

Timeline

Start
2022-08-22
Primary completion
2024-12-28
Completion
2025-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 10 mg Oral

Indications